版本:
中国

BRIEF-Avita Medical says FDA approves continued access to ReCell in US burns trial

Oct 4 Avita Medical Ltd

* US FDA approved continued access to ReCell, allowing US burns surgeons participating in co's regulatory trial to treat new patients using co's cell harvesting device

* Marketing application of ReCell is under preparation and review Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐